Raloxifene is a Selective Estrogen Receptor Modulator (SERM) used in clinics for treating osteoporosis in post-menopausal women and decreasing the risk of invasive breast cancer [34,35]. The gene discussed is ESR1; the disease is invasive breast carcinoma.